Robot-assisted Approach to Cervical Cancer

Prior treatment

• Patients with contraindications to surgery
• Serious concomitant systemic disorders incompatible with the study (at the discretion of the investigator)

Other illness

• Patients with a history of pelvic or abdominal radiotherapy
• Patients with evidence of metastatic disease by conventional imaging, enlarged pelvic or aortic lymph nodes \> 2cm; or histologically positive lymph nodes
• Patients with secondary invasive neoplasm in the last 5 years (except non-melanoma skin cancer, breast cancer T1N0M0 grade 1 or 2 without any signs of recurrence or activity)

Other

• Any histology other than adenocarcinoma, squamous cell carcinoma or adeno-squamous carcinoma of the uterine cervix
• Tumor size greater than 4 cm
• FIGO stage II-IV (except IIA1)
• Patients who are pregnant
• Patients unable to withstand prolonged lithotomy and steep Trendelenburg position

• Histologically confirmed primary adenocarcinoma, squamous cell carcinoma or adeno-squamous carcinoma of the uterine cervix;
• Patients with histologically confirmed stage IB (IB3 excluded) and IIA1, according to the latest revision of the FIGO staging manual
• Patients undergoing either a Type B or C radical hysterectomy (Querleu and Morrow classification)
• Patients with adequate bone marrow, renal and hepatic function
• ECOG Performance Status of 0, 1 or 2.
• Patient must be suitable candidates for surgery.
• Patients who have signed an approved Informed Consent
• Age 18 years or older